主页 > 医学讨论 >
【medical-news】HPV疫苗：宫颈癌的有效预防措施
LONDON -(Dow Jones)- A scientific report published Tuesday by the European Centre for Disease Prevention and Control finds that vaccination against the human papillomavirus (HPV) is an effective prevention strategy against cervical cancer.
Available HPV vaccines protect against two high-risk HPV types that are estimated to be responsible for 73% of cervical cancer cases in Europe, and are spread by sexual contact.
The report identifies young adolescent girls who have not yet become sexually active as the key group to be vaccinated, though "catch-up programmes" for slightly older girls could be helpful in bringing forward the benefits of the vaccine.
The report nonetheless stresses that vaccination is complementary to cervical cancer screening and that a strong emphasis on national screening programmes must be maintained.
While the report provides evidence on when and how HPV vaccination programmes could be effective, decisions on whether to introduce them lie with the E.U. Member States. A number of countries are considering introducing HPV vaccination programmes, and some have already done so. Speaking Tuesday at the European Cervical Cancer Summit in Brussels, Professor Johan Giesecke, ECDC's Chief Scientist said: "Vaccinating young adolescent girls against the Human Papillomavirus is likely to reduce the number of women who develop cervical cancer, provided that cervical cancer screening programmes are maintained. HPV vaccination programmes do not eliminate the need for cervical cancer screening, even for women who have been vaccinated. Screening and HPV vaccination need to be made to work together in a cost-effective way that produces maximum benefit for women."
Cervical cancer is the second most common cancer after breast cancer among women aged 15-44 years in the E.U.
Each year, there are around 33,000 cases of cervical cancer in the E.U., and 15,000 deaths. The primary cause of cervical cancer is persistent infection of the genital tract by a high-risk HPV type.
http://money.***.com/news/newsfeeds/articles/djf500/200801220801DOWJONESDJONLINE000359_FORTUNE5.htm 本人认领此文编译，若48小时未上传，请其他战友自由认领 EU Agency Says Cervical Cancer Vaccination Is Cost Effective
欧盟机构称：子宫颈癌疫苗接种是十分有效的
LONDON -(Dow Jones)- A scientific report published Tuesday by the European Centre for Disease Prevention and Control finds that vaccination against the human papillomavirus (HPV) is an effective prevention strategy against cervical cancer.
伦敦-（道琼斯） -科学报告公布周二由欧洲疾控中心认为，接种疫苗对人类乳头状瘤病毒（H P V）感染导致宫颈癌是一种有效的预防策略。
Available HPV vaccines protect against two high-risk HPV types that are estimated to be responsible for 73% of cervical cancer cases in Europe, and are spread by sexual contact.
有效的人类乳突病毒疫苗对两种高风险的HPV类型的保护作用，估计能对欧洲73%的通过性接触传播病例起保护作用。
The report identifies young adolescent girls who have not yet become sexually active as the key group to be vaccinated, though "catch-up programmes" for slightly older girls could be helpful in bringing forward the benefits of the vaccine.
报告还指出虽然 "追赶行动方案"中，稍年长的女孩能有从提前进行疫苗接种中获益，但年轻少女中尚未成为性活跃期的为疫苗接种的重点对象。
The report nonetheless stresses that vaccination is complementary to cervical cancer screening and that a strong emphasis on national screening programmes must be maintained.
报告中，但强调，接种疫苗与子宫颈癌普查是相辅相成的，并强调必须普及国家筛选方案。
While the report provides evidence on when and how HPV vaccination programmes could be effective, decisions on whether to introduce them lie with the E.U. Member States. A number of countries are considering introducing HPV vaccination programmes, and some have already done so. Speaking Tuesday at the European Cervical Cancer Summit in Brussels, Professor Johan Giesecke, ECDC's Chief Scientist said: "Vaccinating young adolescent girls against the Human Papillomavirus is likely to reduce the number of women who develop cervical cancer, provided that cervical cancer screening programmes are maintained. HPV vaccination programmes do not eliminate the need for cervical cancer screening, even for women who have been vaccinated. Screening and HPV vaccination need to be made to work together in a cost-effective way that produces maximum benefit for women."
而该报告提供的证据显示，在何时及如何进行有效的人类乳头瘤病毒疫苗接种方案，取决于是否与欧盟各会员国一起引进该方案。一些国家正在考虑引进人类乳头瘤病毒疫苗接种方案，有的已经这样做了。在谈到周二在欧洲布鲁塞尔举行的宫颈癌首脑会议上，ECDC的首席科学家Johan giesecke教授说： "对年轻少女针对人类乳头状瘤病毒接种疫苗很有可能降低妇女宫颈癌发生的机率，只要坚持进行宫颈癌筛查。人类乳头瘤病毒疫苗接种方案，即使对已接种疫苗的妇女，也不排除子宫颈抹片检查的必要性。筛查人类乳头瘤病毒疫苗接种必须作出共同努力，以最有效的方式让妇女享受最大的利益"
阅读本文的人还阅读：
作者:admin@医学,生命科学 2011-04-20 05:14
医学,生命科学网